Named by Time as one of the 50 most influential people in healthcare in 2018, Dr. Harper has helped bring well over a dozen novel therapies to patients during his career. In areas as diverse as oncology, osteoporosis, cardiovascular disease and migraine, Dr. Harper’s passion for science and medicine has benefited millions of patients worldwide.
Dr. Harper brings a rare breadth of experience in both basic research and as a practicing physician. He has led a wide range of clinical research programs, from early translational trials to global outcomes studies. As co-founding managing director of Westlake Village BioPartners, Dr. Harper identifies promising new therapies and technologies and builds companies to address significant unmet medical needs.
From 2002 to 2018, Dr. Harper worked for Amgen, rising to become head of R&D in 2012, where he managed investments of more than $3.5 billion annually, applying breakthroughs in science to address some of society’s biggest health challenges.